WallStreetZenWallStreetZen

NASDAQ: ATNF
180 Life Sciences Corp Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
180 Life Sciences earnings were -$15.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ATNF earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.4M, down 80.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATNF reported annual earnings of -$14.2M, with -28.9% growth.

ATNF earnings history

Current Revenue
$0.0
Current Earnings
-$15.5M
Current Profit Margin
0%

ATNF Return on Equity

Current Company
-305.4%
Current Industry
-60.2%
Current Market
31.5%
ATNF's Return on Equity (-305.4%)... subscribe to Premium to read more.
High Return on Equity Performance

ATNF undefined

Current Company
-159.6%
Current Industry
-2.5%
ATNF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ATNF announces earnings.

ATNF undefined

Current Company
-100.23%
Current Industry
5.8%
ATNF's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATNF vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ATNF-$7.69M-$15.48MN/A-$14.76
JBIO-$48.65M-$48.96MN/A-$59.50
CELZ-$5.98M-$6.09MN/A-$3.81
IBO-$22.76M-$25.02MN/A-$2.36
RNAZ-$25.05M-$25.54MN/A-$808,387,293.66
View Top Biotech Stocks

180 Life Sciences Earnings Reports & History FAQ

What were 180 Life Sciences's earnings last quarter?

On ATNF's earnings call on Invalid Date, 180 Life Sciences (NASDAQ: ATNF) reported Q1 2025 earnings per share (EPS) of -$0.67, up 60.12% year over year. Total ATNF earnings for the quarter were -$2.37 million. In the same quarter last year, 180 Life Sciences's earnings per share (EPS) was -$1.68.

If you're new to stock investing, here's how to buy 180 Life Sciences stock.

Is 180 Life Sciences profitable or losing money?

As of the last 180 Life Sciences earnings report, 180 Life Sciences is currently losing money. 180 Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$7.47 million, a 54.02% decrease year over year.

What was ATNF's earnings growth in the past year?

As of 180 Life Sciences's earnings date in Invalid Date, 180 Life Sciences's earnings has grown year over year. ATNF earnings in the past year totalled -$15.48 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.